Le Lézard
Classified in: Health, Business
Subject: AVO

CLHIA Welcomes the Announcement of Advisory Council on the Implementation of Pharmacare


TORONTO, June 20, 2018 /CNW/ - The Canadian Life and Health Insurance Association (CLHIA) welcomes the announcement of the members of the Advisory Council on the Implementation of Pharmacare.  The Advisory Council's work is important to ensuring that all Canadians have access to the affordable prescription medicines they need to keep them well.

"Canada's life and health insurers are ready to work with the Advisory Council as it develops options to ensure access to affordable prescription medicines for everyone," states Stephen Frank, President and CEO of CLHIA.  "The Advisory Council's work is important to help improve our current system so that it works better for all Canadians. Smart reform will ensure that patients have access to the medicines they need at affordable prices, that strong workplace health benefit plans are protected, and that tax dollars are used wisely."

"We look forward to participating in the consultations that the Council will undertake and remain committed to doing our part to improve Canada's system," adds Mr. Frank.

About the CLHIA

The CLHIA is a voluntary association whose member companies account for 99% of Canada's life and health insurance business. The industry provides a wide range of financial security products such as life insurance, annuities (including RRSPs, RRIFs and pensions) and supplementary health insurance to more than 28 million Canadians. It also holds over $810 billion in assets in Canada and employs nearly 155,000 Canadians.

SOURCE Canadian Life and Health Insurance Association Inc.


These press releases may also interest you

at 06:15
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Exciting technical...

at 06:10
Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The 2-year grant...

at 06:08
Aesthetic Management Partners LLC, a manufacturer of skin-based solutions and a provider of energy-based devices announces its collaboration with Croma (Croma-Pharma® GmbH), a global player in the minimally invasive aesthetics market and a leading...

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...



News published on and distributed by: